Country: United States
Language: English
Source: NLM (National Library of Medicine)
VANCOMYCIN HYDROCHLORIDE (UNII: 71WO621TJD) (VANCOMYCIN - UNII:6Q205EH1VU)
PAI Holdings, LLC
ORAL
PRESCRIPTION DRUG
Vancomycin Hydrochloride Capsules are indicated for the treatment of C. difficile -associated diarrhea. Vancomycin Hydrochloride Capsules is also used for the treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains). Parenteral administration of vancomycin is not effective for the above infections; therefore, Vancomycin Hydrochloride Capsules must be given orally for these infections. Orally administered Vancomycin Hydrochloride Capsules is not effective for other types of infections. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Vancomycin Hydrochloride Capsules and other antibacterial drugs, Vancomycin Hydrochloride Capsules should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibact
Vancomycin Hydrochloride Capsules, USP are available in: The 125 mg* CAPSULES have a blue cap and yellow body imprinted with "OP64" on both cap and body in white ink. The 250 mg* CAPSULES have a blue cap and dark-yellow body imprinted with "OP65" on both cap and body in white ink. A carton contains 2 blister packs. Each blister pack contains 10 capsules for a total of 20 capsules per carton. A carton contains 2 blister packs. Each blister pack contains 10 capsules for a total of 20 capsules per carton. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature] *Equivalent to vancomycin.
Abbreviated New Drug Application
VANCOMYCIN HYDROCHLORIDE- VANCOMYCIN HYDROCHLORIDE CAPSULE PAI HOLDINGS, LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE VANCOMYCIN HYDROCHLORIDE CAPSULES SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR VANCOMYCIN HYDROCHLORIDE CAPSULES. VANCOMYCIN HYDROCHLORIDE CAPSULES, FOR ORAL USE INITIAL U.S. APPROVAL: 1986 TO REDUCE THE DEVELOPMENT OF DRUG-RESISTANT BACTERIA AND MAINTAIN THE EFFECTIVENESS OF VANCOMYCIN HYDROCHLORIDE CAPSULES AND OTHER ANTIBACTERIAL DRUGS, VANCOMYCIN HYDROCHLORIDE CAPSULES SHOULD BE USED ONLY TO TREAT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY SUSCEPTIBLE BACTERIA. INDICATIONS AND USAGE Treatment of: ( 1 ) _C. difficile_ -associated diarrhea Enterocolitis caused by _Staphylococcus aureus_ (including methicillin- resistant strains) Important Limitations: ( 1 ) ( 5.1 ) Orally administered vancomycin hydrochloride capsules is not effective for other types of infections. DOSAGE AND ADMINISTRATION • _C. difficile-_ associated diarrhea: Adult Patients (≥18 years of age): 125 mg orally 4 times daily for 10 days. ( 2.1 ) Pediatric Patients (<18 years of age): 40 mg/kg in 3 or 4 divided doses for 7 to 10 days. The total daily dosage should not exceed 2 g. ( 2.2 ) • Staphylococcal enterocolitis: Adult Patients (≥18 years of age): 500 mg to 2 g orally in 3 or 4 divided doses for 7 to 10 days. ( 2.1 ) Pediatric Patients (<18 years of age): 40 mg/kg in 3 or 4 divided doses for 7 to 10 days. The total daily dosage should not exceed 2 g. ( 2.2 ) DOSAGE FORMS AND STRENGTHS 125 mg capsules ( 3 ) 250 mg capsules ( 3 ) CONTRAINDICATIONS Hypersensitivity to vancomycin ( 4 ) (4) WARNINGS AND PRECAUTIONS VANCOMYCIN HYDROCHLORIDE CAPSULES MUST BE GIVEN ORALLY FOR TREATMENT OF STAPHYLOCOCCAL ENTEROCOLITIS AND _C. DIFFICILE_ -ASSOCIATED DIARRHEA. ORALLY ADMINISTERED VANCOMYCIN HYDROCHLORIDE CAPSULES ARE NOT EFFECTIVE FOR OTHER TYPES OF INFECTIONS. ( 5.1 ) Clinically significant serum concentrations have Read the complete document